Loading clinical trials...
Loading clinical trials...
A Prospective, Double-blind, Randomized, Active Controlled, Parallel Group, Multicenter Phase II Clinical Trial to Evaluate the Effectiveness of X-22 as a Smoking Cessation Aid
Conditions
Interventions
X-22 Smoking Cessation Product
Active Control Cigarettes
Locations
3
United States
Benchmark Research Sacramento
Sacramento, California, United States
Benchmark Research New Orleans
Metairie, Louisiana, United States
Benchmark Research Austin
Austin, Texas, United States
Start Date
July 1, 2011
Primary Completion Date
December 1, 2012
Completion Date
December 1, 2012
Last Updated
November 19, 2021
NCT06598397
NCT07441928
NCT07080788
NCT05846841
NCT07210567
NCT05733767
Lead Sponsor
22nd Century Limited, LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions